Company Data
Immunome Inc.
Ticker
IMNM
Current Price
$20.78 -4.81%
Market Cap
$2.4B
Price Target
Refer to Report
Volume
1.5M
52wk Range
$7.96 - $27.65
Overview
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company’s primary focus areas are oncology and infectious disease, including COVID-19.